İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 92
YÖKSİS92 OpenAlex0
Proje 10
Kitap 0
Bildiri 22

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 86
h-indeks 17 Türkiye yüzdelik dilimi: 96 Üniversitesinde h-indekse göre 253. / 2.315
i10-indeks
40
Toplam atıf
1.128
Türkiye’de üst %3,8
Makale başına
13,1
FWCI
1,03
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
7

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 84
  • Q1 30
  • Q2 44
  • Q3 10
  • Q4 0
WoS (JCR) 88
  • Q1 23
  • Q2 32
  • Q3 24
  • Q4 9
TR Index TR Index

2 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 7
  • Ort. 67.1%
  • n 86
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 84

WoS (JCR)

  • YÖKSİS satırı 88

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

45 dergi

Makale listesi

  1. 2025 Biginelli dihydropyrimidines and their acetylated derivatives as L‐/T‐type calcium channel blockers: Synthesis, enantioseparation, and molecular modeling studies Archiv der Pharmazie DOI 10.1002/ardp.202400584 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.5%
  2. 2025 Fabrication of poly(malachite green)/Nafion@nanotubes modified sensor for sensitive analysis of gallic acid and computational-electrochemical approaches on its interaction with human serum albumin Microchemical Journal DOI 10.1016/j.microc.2025.114277 YÖKSİS SJR Q2 JCR Q1 OpenAlex 77.5%
  3. 2025 Screening Natural Phenolic Compounds for Blood‐Brain Barrier Permeability, Alongside GSK‐3β, CK‐1δ, and AChE Inhibition, for the Treatment of Alzheimers Disease Drug Development Research DOI 10.1002/ddr.70193 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.3%
  4. 2025 Cytotoxicity-guided isolation of acacetin derivatives from Cirsium rhizocephalum C.A.Mey. (Asteraceae) and their in silico investigation for androgen receptor inhibition against prostate cancer Chemical Papers DOI 10.1007/s11696-025-04162-w YÖKSİS SJR Q2 JCR Q3 OpenAlex 14.6%
  5. 2025 Hydrazone-bridged 5-nitrofuran and piperidine/piperazine derivatives: Synthesis, DFT studies, and evaluation of anticancer and antimicrobial activity Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.141863 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.2%
  6. 2025 Isoniazid-Derived Hydrazones Featuring Piperazine/Piperidine Rings: Design, Synthesis, and Investigation of Antitubercular Activity Biomolecules DOI 10.3390/biom15091305 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.3%
  7. 2025 From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides Drug Development Research DOI 10.1002/ddr.70191 YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.4%
  8. 2025 Chiral Chromatographic Separation of Fifteen New Hexahydroquinoline Derivatives Chirality DOI 10.1002/chir.70033 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.1%
  9. 2025 Synthesis and Isomerization of Tetrahydro-4H-chromene Derivatives The Journal of Organic Chemistry DOI 10.1021/acs.joc.5c01569 YÖKSİS SJR Q2 JCR Q1 OpenAlex 69.7%
  10. 2025 Synthesis, biological evaluation, molecular modeling, and DFT calculations of novel quinoline-conjugated sulfonyl hydrazones as potential anticancer agents Biochemical and Biophysical Research Communications DOI 10.1016/j.bbrc.2025.152965 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.8%
  11. 2025 Synthesis, molecular modeling, DFT studies, and enantioseparation of tetrahydro-4H-chromene derivatives with calcium channel blocking activity Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.141457 YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.4%
  12. 2024 Azole rings linked to COX inhibitors via hydrazone bridge: Synthesis, stereochemical analysis, and investigation of antimicrobial activity Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.137787 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.0%
  13. 2024 Chiral superficially porous stationary phases for enantiomeric separation of condensed 1,4-dihydropyridine derivatives Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2024.116420 YÖKSİS SJR Q2 JCR Q2 OpenAlex 57.4%
  14. 2024 Electrochemical and Theoretical Investigations on the Binding of Anticancer Drug Olaparib to Human Serum Albumin Journal of The Electrochemical Society DOI 10.1149/1945-7111/ad590d YÖKSİS SJR Q1 JCR Q2 OpenAlex 21.5%
  15. 2024 Biginelli dihydropyrimidines carrying azole rings: Synthesis, computational studies, and evaluation of alpha‐glucosidase inhibitory and antimicrobial activities Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.137802 YÖKSİS SJR Q2 JCR Q2 OpenAlex 67.7%
  16. 2024 Synthesis, molecular modeling, DFT studies, and EPR analysis of 1,4-dihydropyridines as potential calcium channel blockers Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.137983 YÖKSİS SJR Q2 JCR Q2 OpenAlex 75.4%
  17. 2024 Tail‐approach based design, synthesis, and molecular modeling of benzenesulfonamides carrying thiadiazole and urea moieties as novel carbonic anhydrase inhibitors Archiv der Pharmazie DOI 10.1002/ardp.202400439 YÖKSİS SJR Q2 JCR Q2 OpenAlex 64.0%
  18. 2024 Experimental and computational perspectives on the interaction of nerve agent VX metabolite ethyl methylphosphonic acid with human serum albumin Microchemical Journal DOI 10.1016/j.microc.2024.111406 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.8%
  19. 2024 Multivariate Approaches in Quantitative Structure–Property Relationships Study for the Photostability Assessment of 1,4-Dihydropyridine Derivatives Pharmaceutics DOI 10.3390/pharmaceutics16020206 YÖKSİS SJR Q1 JCR Q1 OpenAlex 69.0%
  20. 2024 Expanding cyclodextrin use in normal phase and super/subcritical fluid chromatographic modes for the chiral separation of 1,4-dihydropyridines Journal of Chromatography A DOI 10.1016/j.chroma.2024.465394 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.2%

Akademisyenlere dön